Equillium to attend wells fargo healthcare conference & present at h.c. wainwright 25th annual global investor conference

La jolla, calif.--(business wire)---- $eq--equillium, inc. (nasdaq: eq), a clinical-stage biotechnology company leveraging a deep understanding of immunobiology to develop novel therapeutics to treat severe autoimmune and inflammatory disorders, today announced that it will host investor meetings at the wells fargo healthcare conference, and present and host meetings at the h.c. wainwright 25th annual global investor conference. management will provide an overview of the company's multi-cytokine inhibi.
EQ Ratings Summary
EQ Quant Ranking